Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05003817Phase 3Active Not Recruiting

Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading

Role: collaborator

NCT04557527Not ApplicableCompleted

Suprachoroidal Visco-buckling for the Treatment of Rhegmatogenous Retinal Detachment

Role: collaborator

NCT02782871Not ApplicableWithdrawn

RCT: Compare - Pneupac VR1 to Manual Ventilation in Intubated Patients

Role: collaborator

NCT03617133Phase 2Recruiting

Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Role: collaborator

NCT05065697Unknown

Brain Lesions After Transcatheter Aortic Valve Replacement

Role: collaborator

NCT01769053Not ApplicableTerminated

Variable Pressure Support Trial

Role: collaborator

NCT01581476Phase 3Completed

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

Role: collaborator

NCT02420067Recruiting

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Role: collaborator

NCT01669954Completed

Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study

Role: collaborator

All 9 trials loaded